Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species
these results demonstrate that NKG2D signaling is critical for maximal TNF-alpha (show TNF ELISA Kits) release by NK cells
this study shows that CD20 (show MS4A1 ELISA Kits)-specific immunoligands engaging NKG2D enhance gammadelta T cell-mediated lysis of lymphoma cells
High NKG2D expression is associated with gastric cancer.
Supporting a role for NKG2D ligand expression in controlling the progression of early-stage B cell lymphomas in humans, we found higher expression of a microRNA that inhibits human NKG2D ligand expression in tumor cells from high-grade compared with low-grade follicular lymphoma patients.
On-treatment decrease of NKG2D correlates to early emergence of clinically evident hepatocellular carcinoma after interferon (show IFNA ELISA Kits)-free therapy for chronic hepatitis C
The interaction of Fas receptor (show FAS ELISA Kits) with FasL (show FASL ELISA Kits) leads to an activation of the Tag7 (show PGLYRP1 ELISA Kits)-Hsp70 (show HSP70 ELISA Kits) complex in the lymphocyte membrane fraction, and here FasL (show FASL ELISA Kits) acts as a receptor that induces intracellular signaling in lymphocytes.An interaction of the MicA (show MICA ELISA Kits) stress ligand with the NKG2D receptor is necessary for the release of this cytotoxic complex
Blockade of NKG2D on CD8 (show CD8A ELISA Kits)(+) T cells inhibited the migration over ligand-expressing endothelial cells. Intestinal induction of NKG2D ligands and ligand-induced down-regulation of NKG2D in Crohn's disease (CD) suggest that the NKG2D-ligand interaction may be involved in both the activation and recruitment of NKG2D(+) lymphocytes into the inflamed CD intestine.
IDH (show IDH1 ELISA Kits) mutant glioma cells acquire resistance to natural killer cells through epigenetic silencing of NKG2D ligands ULBP1 (show ULBP1 ELISA Kits) and ULBP3 (show ULBP3 ELISA Kits)
non-virally infected human T cells can express NKG2DL, with implications for stress surveillance by the large number of NKG2D-expressing NK cells sequestered in the liver.
After PSK (show TAOK2 ELISA Kits) administration, INF (show GIF ELISA Kits)-g production in CD8 (show CD8A ELISA Kits)(+) T cells increased in mice with cells expressing neither Rae-1 (show RAE1 ELISA Kits) nor H60, but did not change in mice implanted with cells expressing both Rae-1 (show RAE1 ELISA Kits) and H60. We demonstrated that the expression of NKG2DLs affects tumor immunity and the efficacy of immuno therapy in tumor-bearing mouse model
proposed that TLR9 (show TLR9 ELISA Kits) regulates the NF-kappaB (show NFKB1 ELISA Kits)-NLRP3 (show NLRP3 ELISA Kits)-IL-1beta (show IL1B ELISA Kits) pathway negatively in Salmonella-induced NKG2D-mediated intestinal inflammation and plays a critical role in defense against S. typhimurium infection and in the protection of intestinal integrity.
NKG2D-deficient mice and mice constitutively expressing NKG2D ligands had increased incidence of B cell tumors, confirming that the inability to clear NKG2D ligand-expressing cells was important in tumor suppression and that NKG2D ligand expression is a marker of nascent tumors
data show that NKG2D has a nonredundant role in priming of CD8 (show CD8A ELISA Kits)(+) T cells to produce antiviral cytokines
NKG2D augments Ly49H-dependent proliferation of NK cells; however, NKG2D signaling alone is inadequate for expansion of NK cells, likely due to only transient expression of the NKG2D-DAP12 (show TYROBP ELISA Kits) complex
The elevated cytotoxicity achieved by suppressing mTOR (show FRAP1 ELISA Kits) was a result of up-regulation of NKG2D and TNF-alpha (show TNF ELISA Kits). The inhibition of STAT5 (show STAT5A ELISA Kits) pathways via siRNA interference or a specific inhibitor eliminated the up-regulation of NKG2D and TNF-alpha (show TNF ELISA Kits) in rapamycin-treated Vgamma4 gammadelta T cells.
study demonstrates that the effect of NKG2D on B1a cell development occurs at a developmental stage that precedes the common lymphoid progenitor; findings reveal an unexpected new role for NKG2D in the regulation of B1a cell development
Sirt6 (show SIRT6 ELISA Kits) binds to promoters of NKG2D ligand genes and regulates the H3K9 and H3K56 acetylation levels
These results support the conclusion that svH1C mimics Neu5Ac-containing sequences and interacts with cell-surface receptor NKG2D, which contains a lectin-like domain
These results indicate that, unlike in the pancreas, NKG2D-NKG2D ligand interaction does not play a critical role in obesity-induced inflammation in the adipose tissue.
The results show that NK cells and the NKG2D receptor play a role in control of lymphomas, and that selection of NKG2D-ligand (MULT1 (show ULBP1 ELISA Kits)) loss mutants provides a mechanism for tumor escape.
The effect of Bacillus cereus on the stress response of enterocytes, including the expression of NKG2D, is reported.
Determined expressions of NKG2D in decidual natural killer cells in patients having spontaneous abortions.
Natural killer (NK) cells are lymphocytes that can mediate lysis of certain tumor cells and virus-infected cells without previous activation. They can also regulate specific humoral and cell-mediated immunity. NK cells preferentially express several calcium-dependent (C-type) lectins, which have been implicated in the regulation of NK cell function. The NKG2 gene family is located within the NK complex, a region that contains several C-type lectin genes preferentially expressed in NK cells. This gene encodes a member of the NKG2 family. The encoded transmembrane protein is characterized by a type II membrane orientation (has an extracellular C terminus) and the presence of a C-type lectin domain. It binds to a diverse family of ligands that include MHC class I chain-related A and B proteins and UL-16 binding proteins, where ligand-receptor interactions can result in the activation of NK and T cells. The surface expression of these ligands is important for the recognition of stressed cells by the immune system, and thus this protein and its ligands are therapeutic targets for the treatment of immune diseases and cancers. Read-through transcription exists between this gene and the upstream KLRC4 (killer cell lectin-like receptor subfamily C, member 4) family member in the same cluster.
killer cell lectin-like receptor subfamily K, member 1
, NKG2-D type II integral membrane protein-like
, NK cell receptor D
, NKG2-D type II integral membrane protein
, NKG2-D-activating NK receptor
, natural killer cell group 2D
, NK lectin-like receptor
, NKR-P2, ortholog of human NKG2D
, killer cell lectin-like receptor subfamily K member 1
, NKG2-D activating NK receptor